Literature DB >> 31149915

Poverty and Excess Length of Hospital Stay in Neonatal Opioid Withdrawal Syndrome.

Zachary A Vesoulis1, Christopher E Lust, Barbara A Cohlan, Steve M Liao, Amit M Mathur.   

Abstract

OBJECTIVES: To study the impact of sociodemographic factors on length of stay (LOS) for infants with neonatal opioid withdrawal syndrome (NOWS) secondary to fetal opioid exposure.
METHODS: In this retrospective cohort study, we included term infants with NOWS, excluding those with other significant medical issues. Comprehensive clinical and sociodemographic data were collected. Multivariate regression modeling was used to identify factors which contributed to excess LOS, which was defined as the number of days beyond the standard monitoring and/or treatment protocol.
RESULTS: In all, 129 infants were identified; mean gestational age of 37.9 ± 1.3 weeks and mean body weight of 2880 ± 496 g. Among them, 68% of infants were exposed to opioids; 27% were exposed to methadone; and 67% required pharmacologic treatment. The degree of poverty was assessed using the Area Deprivation Index (ADI) based on the mother's address at the time of birth. Median LOS for treated infants was 23 days versus 8 days for those who did not need pharmacologic treatment. The median excess LOS was 4 days (range 0-24).Excess hospital days were strongly correlated with degree of deprivation in the mother's community (r = 0.55, P < 0.01). ADI remained a strong predictor of excess LOS, even when controlling for pharmacologic treatment, placement in state's custody, race, and gestational age at birth.
CONCLUSIONS: These results suggest poverty is associated with excess LOS and that early allocation of resources for at-risk families may help to reduce overall length of hospital stay.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31149915      PMCID: PMC6881526          DOI: 10.1097/ADM.0000000000000540

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   4.647


  30 in total

1.  Neonatal abstinence syndrome: assessment and management.

Authors:  L P Finnegan; J F Connaughton; R E Kron; J P Emich
Journal:  Addict Dis       Date:  1975

2.  The neonatal withdrawal inventory: a simplified score of newborn withdrawal.

Authors:  W Zahorodny; C Rom; W Whitney; S Giddens; M Samuel; G Maichuk; R Marshall
Journal:  J Dev Behav Pediatr       Date:  1998-04       Impact factor: 2.225

3.  Improving Care for Neonatal Abstinence Syndrome.

Authors:  Stephen W Patrick; Robert E Schumacher; Jeffrey D Horbar; Madge E Buus-Frank; Erika M Edwards; Kate A Morrow; Karla R Ferrelli; Alan P Picarillo; Munish Gupta; Roger F Soll
Journal:  Pediatrics       Date:  2016-04-15       Impact factor: 7.124

4.  Blockade of tolerance to morphine analgesia by cocaine.

Authors:  A L Misra; R B Pontani; N L Vadlamani
Journal:  Pain       Date:  1989-07       Impact factor: 6.961

5.  Neonatal methadone withdrawal. Effect of two treatment regimens.

Authors:  I Carin; L Glass; A Parekh; N Solomon; J Steigman; S Wong
Journal:  Am J Dis Child       Date:  1983-12

6.  Neonatal narcotic abstinence: Effects of pharmacotherapeutic agents and maternal drug usage on nutritive sucking behavior.

Authors:  R E Kron; M Litt; D Eng; M D Phoenix; L P Finnegan
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

7.  Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study.

Authors:  Amy J H Kind; Steve Jencks; Jane Brock; Menggang Yu; Christie Bartels; William Ehlenbach; Caprice Greenberg; Maureen Smith
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

8.  [Neonatal seizures, buprenorphine abstinence syndrome, and substitutive treatment with morphine].

Authors:  S Dahan; E Elefant; I Girard; B Azcona; V Champion; D Mitanchez
Journal:  Arch Pediatr       Date:  2011-01-26       Impact factor: 1.180

9.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

10.  Morphine clearance in children: does race or genetics matter?

Authors:  Senthilkumar Sadhasivam; Elke H J Krekels; Vidya Chidambaran; Hope R Esslinger; Pornswan Ngamprasertwong; Kejian Zhang; Tsuyoshi Fukuda; Alexander A Vinks
Journal:  J Opioid Manag       Date:  2012 Jul-Aug
View more
  1 in total

1.  Association between neighborhood disadvantage and fulfillment of desired postpartum sterilization.

Authors:  Kavita Shah Arora; Mustafa Ascha; Barbara Wilkinson; Emily Verbus; Mary Montague; Jane Morris; Douglas Einstadter
Journal:  BMC Public Health       Date:  2020-09-22       Impact factor: 4.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.